Olafur Eysteinn Sigurjonsson
Overview
Explore the profile of Olafur Eysteinn Sigurjonsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma Q, Piaia L, Loca D, Rubenis K, Locs J, Thiede B, et al.
J Biomed Mater Res A
. 2024 Dec;
113(1):e37848.
PMID: 39692153
The eggshell membrane (ESM), resembling the extracellular matrix (ECM), acts as a protective barrier against bacterial invasion and offers various biofunctions due to its porous structure and protein-rich composition, such...
2.
Boretti G, Baldursson H, Buonarrivo L, Simonsson S, Brynjolfsson S, Gargiulo P, et al.
Polymers (Basel)
. 2024 Oct;
16(19).
PMID: 39408454
Articular cartilage degeneration poses a significant public health challenge; techniques such as 3D bioprinting are being explored for its regeneration Gelatin-based hydrogels represent one of the most promising biopolymers used...
3.
Boretti G, Giordano E, Ionita M, Vlasceanu G, Sigurjonsson O, Gargiulo P, et al.
Materials (Basel)
. 2023 Sep;
16(17).
PMID: 37687590
Tissue-engineered bone tissue grafts are a promising alternative to the more conventional use of natural donor bone grafts. However, choosing an appropriate biomaterial/scaffold to sustain cell survival, proliferation, and differentiation...
4.
Apelseth T, Doyle B, Evans R, George C, Humbrecht C, Klei T, et al.
Transfusion
. 2023 Apr;
63 Suppl 3:S105-S111.
PMID: 37057621
Background: New blood products are considered for treatment of patients with major hemorrhage. The aim of this report is to describe the current transfusion practices in Europe for patients with...
5.
Metabolic and Transcriptional Changes across Osteogenic Differentiation of Mesenchymal Stromal Cells
Sigmarsdottir T, McGarrity S, de Lomana A, Kotronoulas A, Sigurdsson S, Yurkovich J, et al.
Bioengineering (Basel)
. 2021 Dec;
8(12).
PMID: 34940360
Mesenchymal stromal cells (MSCs) are multipotent post-natal stem cells with applications in tissue engineering and regenerative medicine. MSCs can differentiate into osteoblasts, chondrocytes, or adipocytes, with functional differences in cells...
6.
Sigmarsdottir T, McGarrity S, Yurkovich J, Rolfsson O, Sigurjonsson O
Front Cell Dev Biol
. 2021 Jun;
9:642681.
PMID: 34150750
Since their initial discovery in 1976, mesenchymal stem cells (MSCs) have been gathering interest as a possible tool to further the development and enhancement of various therapeutics within regenerative medicine....
7.
Desmirean M, Rauch S, Jurj A, Pasca S, Iluta S, Teodorescu P, et al.
J Clin Med
. 2020 Oct;
9(11).
PMID: 33114418
Malignant lymphomas are a heterogeneous group of malignancies that develop both in nodal and extranodal sites. The different tissues involved and the highly variable clinicopathological characteristics are linked to the...
8.
Zimta A, Sigurjonsson O, Gulei D, Tomuleasa C
Int J Mol Sci
. 2020 Aug;
21(16).
PMID: 32824183
Nowadays, advancements in the oncology sector regarding diagnosis methods allow us to specifically detect an increased number of cancer patients, some of them in incipient stages. However, one of the...
9.
Constantinescu C, Pasca S, Tat T, Teodorescu P, Vlad C, Iluta S, et al.
J Immunother Cancer
. 2020 Jun;
8(1).
PMID: 32474415
Recently, an increasing number of novel drugs were approved in oncology and hematology. Nevertheless, pharmacology progress comes with a variety of side effects, of which cytokine release syndrome (CRS) is...
10.
Christensen C, Jonsdottir-Buch S, Sigurjonsson O
PLoS One
. 2020 Apr;
15(4):e0220163.
PMID: 32294080
Background: Clinical application of mesenchymal stromal cells (MSCs) usually requires an in vitro expansion step to reach clinically relevant numbers. In vitro cell expansion necessitates supplementation of basal mammalian cell...